Clinical Trial

CANnabinoids in Pediatric ONCology

Study acronym: CAN-PONC
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
CANnabinoids in Pediatric ONCology is a randomized, double blind, adaptive clinical trial looking at the tolerability of cannabinoids in children with cancer across 3 Canadian children's hospitals.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-03; most recent amendment 2026-06-09.
Status change: Not Yet Recruiting → Recruiting 2026-06-09
Trial Details
NCT Number NCT05754840
Lead Sponsor University of Manitoba
Collaborators: Canadian Cancer Society (CCS), Canadian Institutes of Health Research (CIHR)
Conditions Childhood Cancer, Cancer
Enrollment 60 participants
Start Date 2025-07-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-11